Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


13.11.2017

1 Am J Clin Oncol
1 Am J Respir Cell Mol Biol
2 Ann Oncol
11 Ann Thorac Surg
2 Arch Bronconeumol
1 Arch Pathol Lab Med
3 BMC Cancer
1 BMJ
2 Br J Cancer
1 Cancer
3 Cancer Chemother Pharmacol
2 Cancer Lett
2 Cancer Res
1 Carcinogenesis
1 Clin Lung Cancer
1 Clin Nucl Med
2 Eur J Cardiothorac Surg
3 Int J Radiat Oncol Biol Phys
2 J Cancer Res Clin Oncol
1 J Clin Oncol
1 J Nucl Med
2 J Thorac Cardiovasc Surg
16 Lung Cancer
1 Lung Cancer (Auckl)
1 Nat Rev Cancer
1 Oncol Rep
5 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Oncol

  1. JEREMIC B
    Induction Therapies Plus Surgery Versus Exclusive Radiochemotherapy in Stage IIIA/N2 Non-Small Cell Lung Cancer (NSCLC).
    Am J Clin Oncol. 2017 Nov 7. doi: 10.1097/COC.0000000000000416.
    PubMed     Text format     Abstract available


    Am J Respir Cell Mol Biol

  2. ELANGOVAN IM, Vaz M, Tamatam CR, Potteti HR, et al
    FOSL1 Promotes Kras-Induced Lung Cancer Through Amphiregulin and Cell Survival Gene Regulation.
    Am J Respir Cell Mol Biol. 2017 Nov 7. doi: 10.1165/rcmb.2017-0164.
    PubMed     Text format     Abstract available


    Ann Oncol

  3. HENTRICH M, Schipek-Voigt K, Jager H, Schulz S, et al
    Nivolumab in HIV-related non-small-cell lung cancer.
    Ann Oncol. 2017 Jul 6. doi: 10.1093.
    PubMed     Text format    

  4. EK L, Gezelius E, Bergman B, Bendahl PO, et al
    Randomized Phase III Trial of Low Molecular Weight Heparin Enoxaparin in Addition to Standard Treatment in Small Cell Lung Cancer: the RASTEN Trial.
    Ann Oncol. 2017 Nov 2. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  5. OH DS, Reddy RM, Gorrepati ML, Mehendale S, et al
    Robotic-Assisted, Video-Assisted Thoracoscopic and Open Lobectomy: Propensity-Matched Analysis of Recent Premier Data.
    Ann Thorac Surg. 2017;104:1733-1740.
    PubMed     Text format     Abstract available

  6. SEDER CW, Arndt AT, Jordano L, Basu S, et al
    Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters.
    Ann Thorac Surg. 2017;104:1637-1643.
    PubMed     Text format     Abstract available

  7. YENDAMURI S, Battoo A, Dy G, Chen H, et al
    Transcervical Extended Mediastinal Lymphadenectomy: Experience From a North American Cancer Center.
    Ann Thorac Surg. 2017;104:1644-1649.
    PubMed     Text format     Abstract available

  8. ABDELSATTAR ZM, Shen KR, Yendamuri S, Cassivi S, et al
    Outcomes After Sleeve Lung Resections Versus Pneumonectomy in the United States.
    Ann Thorac Surg. 2017;104:1656-1664.
    PubMed     Text format     Abstract available

  9. STAMATIS G, Fechner S, Rocha M, Weinreich G, et al
    Resection of the Tracheobronchial Bifurcation With Complete Preservation of Lung Parenchyma.
    Ann Thorac Surg. 2017;104:1741-1747.
    PubMed     Text format     Abstract available

  10. BURT BM, Lee HS, Lenge De Rosen V, Hamaji M, et al
    Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma.
    Ann Thorac Surg. 2017;104:1679-1687.
    PubMed     Text format     Abstract available

  11. GOSSOT D, Lutz JA, Grigoroiu M, Brian E, et al
    Unplanned Procedures During Thoracoscopic Segmentectomies.
    Ann Thorac Surg. 2017;104:1710-1717.
    PubMed     Text format     Abstract available

  12. KAPADIA NS, Valle LF, George JA, Jagsi R, et al
    Patterns of Treatment and Outcomes for Definitive Therapy of Early Stage Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2017 Oct 17. pii: S0003-4975(17)30967.
    PubMed     Text format     Abstract available

  13. WAKEAM E, Byrne JP, Darling GE, Varghese TK Jr, et al
    Surgical Treatment for Early Small Cell Lung Cancer: Variability in Practice and Impact on Survival.
    Ann Thorac Surg. 2017 Oct 26. pii: S0003-4975(17)30984.
    PubMed     Text format     Abstract available

  14. BHAGAT R, Bronsert MR, Ward AN, Martin J, et al
    National Analysis of Unplanned Readmissions After Thoracoscopic Versus Open Lung Cancer Resection.
    Ann Thorac Surg. 2017 Nov 1. pii: S0003-4975(17)31194.
    PubMed     Text format     Abstract available

  15. KRANTZ SB, Lutfi W, Kuchta K, Wang CH, et al
    Improved Lymph Node Staging in Early-Stage Lung Cancer in the National Cancer Database.
    Ann Thorac Surg. 2017 Oct 25. pii: S0003-4975(17)30969.
    PubMed     Text format     Abstract available


    Arch Bronconeumol

  16. GOROSPE SARASUA L, Gonzalez-Garcia A, Garcia Gomez-Muriel I
    Extensive Cavitary Lung Cancer Mimicking Paraesophageal Hiatal Hernia.
    Arch Bronconeumol. 2017 Nov 1. pii: S0300-2896(17)30297.
    PubMed     Text format    

  17. ZHU X, Gu J, Qian H
    Esculetin Attenuates the Growth of Lung Cancer by Downregulating Wnt Targeted Genes and Suppressing NF-kappaB.
    Arch Bronconeumol. 2017 Nov 3. pii: S0300-2896(17)30301.
    PubMed     Text format     Abstract available


    Arch Pathol Lab Med

  18. DRIVER BR, Miller RA, Miller T, Deavers M, et al
    Programmed Death Ligand-1 (PD-L1) Expression in Either Tumor Cells or Tumor-Infiltrating Immune Cells Correlates With Solid and High-Grade Lung Adenocarcinomas.
    Arch Pathol Lab Med. 2017;141:1529-1532.
    PubMed     Text format     Abstract available


    BMC Cancer

  19. ERNST J, Mehnert A, Dietz A, Hornemann B, et al
    Perceived stigmatization and its impact on quality of life - results from a large register-based study including breast, colon, prostate and lung cancer patients.
    BMC Cancer. 2017;17:741.
    PubMed     Text format     Abstract available

  20. KRISHNASWAMY S, Mohammed AK, Tripathi G, Alokail MS, et al
    Splice variants of the extracellular region of RON receptor tyrosine kinase in lung cancer cell lines identified by PCR and sequencing.
    BMC Cancer. 2017;17:738.
    PubMed     Text format     Abstract available

  21. WANG T, Chen X, Qiao W, Kong L, et al
    Transcription factor E2F1 promotes EMT by regulating ZEB2 in small cell lung cancer.
    BMC Cancer. 2017;17:719.
    PubMed     Text format     Abstract available


    BMJ

  22. DIMITRAKOPOULOU VI, Tsilidis KK, Haycock PC, Dimou NL, et al
    Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.
    BMJ. 2017;359:j4761.
    PubMed     Text format     Abstract available


    Br J Cancer

  23. O'SULLIVAN D, Dowling P, Joyce H, McAuley E, et al
    A novel inhibitory anti-invasive MAb isolated using phenotypic screening highlights AnxA6 as a functionally relevant target protein in pancreatic cancer.
    Br J Cancer. 2017;117:1326-1335.
    PubMed     Text format     Abstract available

  24. THALER J, Sigel C, Beasley MB, Wisnivesky J, et al
    Clinically significant mutations in HIV-infected patients with lung adenocarcinoma.
    Br J Cancer. 2017;117:1392-1395.
    PubMed     Text format     Abstract available


    Cancer

  25. SPIEGEL ML, Goldman JW, Wolf BR, Nameth DJ, et al
    Non-small cell lung cancer clinical trials requiring biopsies with biomarker-specific results for enrollment provide unique challenges.
    Cancer. 2017 Nov 10. doi: 10.1002/cncr.31056.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  26. SAKURAI R, Tomizawa Y, Yoshii A, Miura Y, et al
    A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer.
    Cancer Chemother Pharmacol. 2017 Nov 9. doi: 10.1007/s00280-017-3439.
    PubMed     Text format     Abstract available

  27. SCHMID U, Liesenfeld KH, Fleury A, Dallinger C, et al
    Population pharmacokinetics of nintedanib, an inhibitor of tyrosine kinases, in patients with non-small cell lung cancer or idiopathic pulmonary fibrosis.
    Cancer Chemother Pharmacol. 2017 Nov 8. doi: 10.1007/s00280-017-3452.
    PubMed     Text format     Abstract available

  28. MURAKAMI S, Saito H, Kondo T, Ito H, et al
    Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer.
    Cancer Chemother Pharmacol. 2017 Nov 7. doi: 10.1007/s00280-017-3460.
    PubMed     Text format     Abstract available


    Cancer Lett

  29. JING L, Song F, Liu Z, Li J, et al
    MLKL-PITPalpha signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells.
    Cancer Lett. 2017 Nov 2. pii: S0304-3835(17)30693.
    PubMed     Text format     Abstract available

  30. XUE X, Fei X, Hou W, Zhang Y, et al
    miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer.
    Cancer Lett. 2017;412:170-178.
    PubMed     Text format     Abstract available


    Cancer Res

  31. WANG W, Huang L, Jin JY, Jolly S, et al
    IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients.
    Cancer Res. 2017 Nov 8. pii: canres.2995.2017.
    PubMed     Text format     Abstract available

  32. KWAK JW, Laskowski J, Li HY, McSharry MV, et al
    Complement activation via a C3a receptor pathway alters CD4+ T lymphocytes and mediates lung cancer progression.
    Cancer Res. 2017 Nov 8. pii: canres.0240.2017.
    PubMed     Text format     Abstract available


    Carcinogenesis

  33. BASSIG BA, Dai Y, Vermeulen R, Ren D, et al
    Occupational exposure to diesel engine exhaust and alterations in immune/inflammatory markers: a cross-sectional molecular epidemiology study in China.
    Carcinogenesis. 2017;38:1104-1111.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  34. ABUODEH Y, Naghavi AO, Echevarria M, DeMarco M, et al
    Quantitatively Excessive Normal Tissue Toxicity and Poor Target Coverage in Postoperative Lung Cancer Radiotherapy Meta-analysis.
    Clin Lung Cancer. 2017 Jul 8. pii: S1525-7304(17)30196.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  35. SHARMA A, Mohan A, Bhalla AS, Sharma MC, et al
    Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy.
    Clin Nucl Med. 2017 Nov 3. doi: 10.1097/RLU.0000000000001886.
    PubMed     Text format     Abstract available


    Eur J Cardiothorac Surg

  36. SAWABATA N
    Pulmonary wedge resection for Stage I non-small-cell lung cancer: possible alternative strategy to lobectomy.
    Eur J Cardiothorac Surg. 2017 Nov 3. doi: 10.1093.
    PubMed     Text format    

  37. YANG CC, Fong Y, Lin LC, Que J, et al
    The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices.
    Eur J Cardiothorac Surg. 2017 Jul 4. doi: 10.1093.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  38. VAN DER VELDEN JM, Peters M, Verlaan JJ, Versteeg AL, et al
    Development and Internal Validation of a Clinical Risk Score to Predict Pain Response After Palliative Radiation Therapy in Patients With Bone Metastases.
    Int J Radiat Oncol Biol Phys. 2017;99:859-866.
    PubMed     Text format     Abstract available

  39. ERIKSSON M, Haag P, Brzozowska B, Lipka M, et al
    Analysis of Chromatin Opening in Heterochromatic Non-Small cell Lung Cancer Tumor-Initiating Cells in Relation to DNA-Damaging Antitumor Treatment.
    Int J Radiat Oncol Biol Phys. 2017 Sep 22. pii: S0360-3016(17)33933.
    PubMed     Text format     Abstract available

  40. RONDEN MI, van Sornsen de Koste JR, Johnson C, Slotman BJ, et al
    Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Sep 22. pii: S0360-3016(17)33935.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  41. KIM HR, Kim SY, Kim CH, Yang SH, et al
    Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis.
    J Cancer Res Clin Oncol. 2017;143:2283-2290.
    PubMed     Text format     Abstract available

  42. XIONG Y, Wang L, Wang S, Wang M, et al
    SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2017 Nov 4. doi: 10.1007/s00432-017-2537.
    PubMed     Text format     Abstract available


    J Clin Oncol

  43. SCHNEIDER BJ, Daly ME, Kennedy EB, Antonoff MB, et al
    Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.
    J Clin Oncol. 2017 Nov 6:JCO2017749671. doi: 10.1200/JCO.2017.74.9671.
    PubMed     Text format     Abstract available


    J Nucl Med

  44. OLIN A, Ladefoged CN, Langer NH, Keller SH, et al
    Reproducibility of MR-based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer.
    J Nucl Med. 2017 Nov 9. pii: jnumed.117.198853. doi: 10.2967/jnumed.117.198853.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  45. ZHANG Z, Mostofian F, Ivanovic J, Gilbert S, et al
    All grades of severity of postoperative adverse events are associated with prolonged length of stay after lung cancer resection.
    J Thorac Cardiovasc Surg. 2017 Sep 28. pii: S0022-5223(17)32135.
    PubMed     Text format     Abstract available

  46. TURNA A, Melek H, Kara HV, Kilic B, et al
    Validity of the updated European Society of Thoracic Surgeons staging guideline in lung cancer patients.
    J Thorac Cardiovasc Surg. 2017 Sep 27. pii: S0022-5223(17)32131.
    PubMed     Text format     Abstract available


    Lung Cancer

  47. HASSAN A, Latif MT, Soo CI, Faisal AH, et al
    Short communication: Diagnosis of lung cancer increases during the annual southeast Asian haze periods.
    Lung Cancer. 2017;113:1-3.
    PubMed     Text format     Abstract available

  48. SPIGEL DR, Rubin MS, Gian VG, Shipley DL, et al
    Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the Sarah Cannon Research Institute (SCRI).
    Lung Cancer. 2017;113:79-84.
    PubMed     Text format     Abstract available

  49. AHMED Z, Grover P, Kennedy KF, Masood A, et al
    Predictors for chemotherapy in early stage small cell lung carcinoma (SCLC): A National Cancer Database (NCDB) analysis.
    Lung Cancer. 2017;113:85-87.
    PubMed     Text format    

  50. KATO T, Jin CS, Ujiie H, Lee D, et al
    Nanoparticle targeted folate receptor 1-enhanced photodynamic therapy for lung cancer.
    Lung Cancer. 2017;113:59-68.
    PubMed     Text format     Abstract available

  51. LEE CK, Kim S, Lee JS, Lee JE, et al
    Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs.
    Lung Cancer. 2017;113:106-114.
    PubMed     Text format     Abstract available

  52. KAWANO Y, Iwama E, Tsuchihashi K, Shibahara D, et al
    CD44 variant-dependent regulation of redox balance in EGFR mutation-positive non-small cell lung cancer: A target for treatment.
    Lung Cancer. 2017;113:72-78.
    PubMed     Text format     Abstract available

  53. TALBOT T, Dangoor A, Shah R, Naik J, et al
    The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study.
    Lung Cancer. 2017;113:115-120.
    PubMed     Text format     Abstract available

  54. SCHMIDT LH, Stucke-Ring J, Brand C, Schliemann C, et al
    CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer.
    Lung Cancer. 2017;113:121-127.
    PubMed     Text format     Abstract available

  55. HORN L, Gettinger S, Camidge DR, Smit EF, et al
    Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib.
    Lung Cancer. 2017;113:51-58.
    PubMed     Text format     Abstract available

  56. HEUVELMANS MA, Walter JE, Peters RB, Bock GH, et al
    Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
    Lung Cancer. 2017;113:45-50.
    PubMed     Text format     Abstract available

  57. HOCHMAIR MJ, Schwab S, Burghuber OC, Krenbek D, et al
    Symptomatic pseudo-progression followed by significant treatment response in two lung cancer patients treated with immunotherapy.
    Lung Cancer. 2017;113:4-6.
    PubMed     Text format     Abstract available

  58. CORRALES-RODRIGUEZ L, Arrieta O, Mas L, Baez-Saldana R, et al
    An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP).
    Lung Cancer. 2017;113:30-36.
    PubMed     Text format     Abstract available

  59. LIU C, Cui H, Gu D, Zhang M, et al
    Genetic polymorphisms and lung cancer risk: Evidence from meta-analyses and genome-wide association studies.
    Lung Cancer. 2017;113:18-29.
    PubMed     Text format     Abstract available

  60. BOUAZZA YB, Chiairi I, El Kharbouchi O, De Backer L, et al
    Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review.
    Lung Cancer. 2017;113:140-151.
    PubMed     Text format     Abstract available

  61. SANTONI-RUGIU E, Grauslund M, Melchior LC, Costa JC, et al
    Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation.
    Lung Cancer. 2017;113:14-17.
    PubMed     Text format     Abstract available

  62. ICHIKAWA T, Saruwatari K, Mimaki S, Sugano M, et al
    Immunohistochemical and genetic characteristics of lung cancer mimicking organizing pneumonia.
    Lung Cancer. 2017;113:134-139.
    PubMed     Text format     Abstract available


    Lung Cancer (Auckl)

  63. ISOBE H, Mori K, Minato K, Katsura H, et al
    Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan.
    Lung Cancer (Auckl). 2017;8:191-206.
    PubMed     Text format     Abstract available


    Nat Rev Cancer

  64. GAZDAR AF, Bunn PA, Minna JD
    Small-cell lung cancer: what we know, what we need to know and the path forward.
    Nat Rev Cancer. 2017 Nov 10. doi: 10.1038/nrc.2017.
    PubMed     Text format     Abstract available


    Oncol Rep

  65. NI X, Cao X, Wu Y, Wu J, et al
    FSTL1 suppresses tumor cell proliferation, invasion and survival in non-small cell lung cancer.
    Oncol Rep. 2017 Oct 31. doi: 10.3892/or.2017.6061.
    PubMed     Text format     Abstract available


    PLoS One

  66. LIU K, Zheng D, Xu G, Du Z, et al
    Local thoracic therapy improve prognosis for stage IV non-small cell lung cancer patients combined with chemotherapy: A Surveillance, Epidemiology, and End Results database analysis.
    PLoS One. 2017;12:e0187350.
    PubMed     Text format     Abstract available

  67. ARNS A, Blessing M, Fleckenstein J, Stsepankou D, et al
    Phantom-based evaluation of dose exposure of ultrafast combined kV-MV-CBCT towards clinical implementation for IGRT of lung cancer.
    PLoS One. 2017;12:e0187710.
    PubMed     Text format     Abstract available

  68. CHEN YF, Yuan A, Cho KH, Lu YC, et al
    Functional evaluation of therapeutic response of HCC827 lung cancer to bevacizumab and erlotinib targeted therapy using dynamic contrast-enhanced and diffusion-weighted MRI.
    PLoS One. 2017;12:e0187824.
    PubMed     Text format     Abstract available

  69. JABS V, Edlund K, Konig H, Grinberg M, et al
    Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer.
    PLoS One. 2017;12:e0187246.
    PubMed     Text format     Abstract available

  70. FRENZEL T, Hoffmann B, Schmitz R, Bethge A, et al
    Radiotherapy and chemotherapy change vessel tree geometry and metastatic spread in a small cell lung cancer xenograft mouse tumor model.
    PLoS One. 2017;12:e0187144.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: